Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Crédit Agricole Toulouse 31 Initiatives is a venture capital firm based in Toulouse, France, serving as the investment arm of the Crédit Agricole Toulouse 31 regional bank. The fund specializes in providing equity and near-equity financing to innovative startups and small-to-medium enterprises (SMEs) located in the Haute-Garonne region. It maintains a significant investment focus on the life sciences, biotechnology, and healthcare sectors, supporting companies from seed stages through growth. By leveraging its regional expertise and the resources of the broader Crédit Agricole group, the firm acts as a strategic partner to foster local innovation and economic development. Notable portfolio companies include regional leaders in gene therapy, nanomedicine, and medical technology.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Crédit Agricole Toulouse 31 Initiatives.